A Pilot Study to Determine the Feasibility and Utility of Implementing of the Full Scale TOM Trial
Status:
Completed
Trial end date:
2016-11-01
Target enrollment:
Participant gender:
Summary
The primary aim of the pilot (SAPS) protocol is to determine the feasibility and utility of
implementing the provisional design of the full scale TOM trial (e.g., the six month
treatment period, the impact of the smoking cessation intervention).
There is no active hypothesis for the Vanguard Protocol.
Phase:
Phase 4
Details
Lead Sponsor:
University of California, San Diego
Collaborator:
National Heart, Lung, and Blood Institute (NHLBI)
Treatments:
Fluticasone Fluticasone Propionate, Salmeterol Xinafoate Drug Combination Fluticasone-Salmeterol Drug Combination Ipratropium Montelukast Salmeterol Xinafoate Theophylline Xhance